Oral brepocitinib 30 mg was superior to placebo for treating dermatomyositis in adults already receiving standard therapies, according to phase 3 data presented at the American Academy of Dermatology ...
Elon Musk introduced his "Terafab" vision last week.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results